A natural biodrug targeting melanomas with varying mutational status

 This project helped develop a natural therapeutic protein for treating skin cancer that varies in their mutational and drug-resistant status. It helped target molecules and markers that were critical in skin cancer development and progression. It also focused on the importance of using natural therapeutics when compared to other treatment regimens.